In gastric cancer, lower levels of HHLA2 mRNA in the blood was reportedly associated with tumor aggressiveness, adverse prognosis, and lesser 5-year survival rates [16], whereas the overexpression of HHLA2 in cancer tissues was correlated with poor overall survival [17]. This evidence concerns the gene HHLA2 and cancer.